MEOW-1 Trial Starts: What to Know About 'Cat Ozempic' - OKAVA

Our Vision
Products & Science
News & Insights
About Us
Investors

Our Vision
Products & Science
News & Insights
About Us
Investors

OKAVA-site-identity-light

San Francisco, CA

Linkedin-in Instagram

About Us

Meet Our Team / Our Vision / Media Coverage

Products

Human to Pet Pipeline / OKV-119 / OKV-1001 / Publications

For vets

Medicine in Development / Participate in a Study / Our Science Library

For Pet Parents

Our Vision for Pet Health / Conditions We Treat / How We Leverage Human Medicines for Pets

Investors

Pet health market / Corporate Deck / Advantages over human BioPharma

Contact Us

General Inquiries / Investors / Press Contact

News & Insights

MEOW-1 Trial Starts: What to Know About ‘Cat Ozempic’

December 13, 2025
8:32 am

Read Full Article

PrevPreviousOverweight Cats Weight Loss – GLP-1

NextCould weight loss drugs be used to treat obese petsNext

Bringing human medical breakthroughs to pets because every pet deserves a longer, healthier life.

Join Our Studies

San Francisco, CA

Linkedin-in Instagram

Follow Our News & Announcements

Email

Copyright © 2026 Okava Pharmaceuticals. All rights reserved.

Privacy Policy
Terms & Conditions

Privacy Policy
Terms & Conditions